MEGHAN ROGERS: Open Payments
NPI 1255883955 · EATONTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 37 payments from 13 companies in 2025. Trend: 2023 $474 · 2024 $626 · 2025 $845
Food & beverage: $787Education: $57
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $260 |
| Viatris Specialty LLC | 7 | $138 |
| GlaxoSmithKline, LLC. | 5 | $78 |
| Insmed, Inc. | 3 | $58 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| JAZZ PHARMACEUTICALS INC. | 3 | $54 |
| HARMONY BIOSCIENCES LLC | 2 | $39 |
| United Therapeutics Corporation | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 2 | $32 |
Products named: FASENRA, YUPELRI, DUPIXENT, Arikayce, XYWAV, TRELEGY ELLIPTA, WAKIX, Tyvaso.
Industry payments across NJ — which companies pay providers there.
